Budapest 2018 Programme Information

Please filter items using the Days and topics below. TO show all tick the show all button on the filter tool.


All Days Fri 16th Sat 17th
timer Loading ... please wait

Filter by Topic


Thu 15 1500

Registration Desk Opens

1500-1800 | Room: Registration Area
Fri 16 0730

Registration Desk Open

0730-1800 | Room: Registration Area
Fri 16 0900

Welcome Address

0900-0905 | Room: Ballroom II & III

A. Facskó HUNGARY
PRESIDENT, HUNGARIAN SOCIETY OF OPHTHALMOLOGY

J. van Meurs THE NETHERLANDS
CHAIRPERSON, EURETINA WINTER MEETING

Fri 16 0905

Session: Diabetic Retinopathy

0905-1100 | Room: Ballroom II & III
Fri 16 0906

Session Presentation: The role of systemic and ophthalmic biomarkers in Diabetic Retinopathy

0906-0920 | Room: Ballroom II & III
Fri 16 0920

Session Presentation: What is new in our understanding of the pathogenesis of early and late diabetic retinopathy

0920-0935 | Room: Ballroom II & III
Fri 16 0935

Session Presentation: Screening-focus on practical introduction of screening programmes and on developments in automated screening

0935-0950 | Room: Ballroom II & III
Fri 16 0950

Session Presentation: DME: practical application of DME trial outcomes, role of laser and management of chronic DME

0950-1005 | Room: Ballroom II & III
Fri 16 1005

Session Presentation: PDR-focus on pros and cons of anti-VEGF in PDR and management/surgery in advanced retinopathy

1005-1020 | Room: Ballroom II & III
Fri 16 1100

Session: Diabetic Imaging

1100-1230 | Room: Ballroom II & III
Fri 16 1100

Session Presentation: Widefield retinal imaging

1100-1110 | Room: Ballroom II & III
Fri 16 1110

Session Presentation: Understanding OCT-angiography imaging

1110-1120 | Room: Ballroom II & III
MS
Fri 16 1120

Session Presentation: Monitoring and predictive imaging markers in neovascular AMD

1120-1130 | Room: Ballroom II & III
MS
Fri 16 1130

Session Presentation: Data for free: modes of autofluorescence imaging

1130-1140 | Room: Ballroom II & III
MS
Fri 16 1140

Session Presentation: Intraoperative OCT

1140-1150 | Room: Ballroom II & III
MS
Fri 16 1150

Session Presentation: Automated analysis of retinal imaging using machine learning techniques

1150-1200 | Room: Ballroom II & III
MS
Fri 16 1430

Session: Vitreoretinal Surgery

1430-1600 | Room: Ballroom II & III
Fri 16 1430

Session Presentation: Choice of retinal detachment procedure: Buckle vs vitrectomy vs pneumatic retinopexy, choice of tamponade agents, encirclement versus segmental buckle

1430-1445 | Room: Ballroom II & III
MS
Fri 16 1445

Session Presentation: Expected RD outcomes: Complexity based outcome assessment: EURETINA BEAVRS database results

1445-1455 | Room: Ballroom II & III
MS
Fri 16 1455

Session Presentation: Macular holes: theory of evolution, traction vs bistable, size based prognosticaitons, surgery, peel and flaps, tamponade and posture

1455-1510 | Room: Ballroom II & III
MS
Fri 16 1510

Session Presentation: Vitrectomy in diabetic retinopathy: haemeorrhage: traction versus proliferation, angiofibrotic switch, vitrecotmy versus more laser or anti-VEGF, vitreo macular traction/trd, avastin, delam, gauge wars, increased success with surgical evolution

1510-1525 | Room: Ballroom II & III
MS
Fri 16 1525

Session Presentation: Combined phako vitrectomy, local vs general anaesthesia, peribulbar/sub tenons/retorobulbar blocks

1525-1535 | Room: Ballroom II & III
MS
Fri 16 1615

Session: Clinical Cases

1615-1745 | Room: Ballroom II & III
MS
Sat 17 0700

Registration Desk Open

0700-1300 | Room: Registration Area
Sat 17 0800

Session: AMD: A State of the Art in Diagnostics & Therapy

0800-0930 | Room: Ballroom II & III
Sat 17 0800

Session Presentation: Diagnostic and prognostic markers in wet AMD

0800-0810 | Room: Ballroom II & III
MS
Sat 17 0810

Session Presentation: Real life data on the efficacy of antiVEGF

0810-0820 | Room: Ballroom II & III
MS
Sat 17 0820

Session Presentation: OCTA and choroidal neovascularization

0820-0830 | Room: Ballroom II & III
MS
Sat 17 0830

Session Presentation: Latest clinical trials in neovascular AMD

0830-0840 | Room: Ballroom II & III
MS
Sat 17 0840

Session Presentation: Geographic atrophy: more than one phenotype

0840-0850 | Room: Ballroom II & III
MS
Sat 17 1000

Session: Uveitis/Inflammation

1000-1130 | Room: Ballroom II & III
Sat 17 1010

Session Presentation: Preferred practice patterns in uveitis: Getting it right most of the time

1010-1020 | Room: Ballroom II & III
MS
Sat 17 1020

Session Presentation: New treatment in uveitis: Beyond the Biologics

1020-1030 | Room: Ballroom II & III
MS
Sat 17 1030

Session Presentation: Infectious Uveitis : The Trouble with TB

1030-1040 | Room: Ballroom II & III
MS
Sat 17 1040

Session Presentation: Imaging in Uveitis: Insights into pathology from technology

1040-1050 | Room: Ballroom II & III
Sat 17 1040

Session Presentation: Imaging in Uveitis: Insights into pathology from technology

1040-1050 | Room: Ballroom II & III
MS
Sat 17 1145

Quick Fire Free Paper Session

1145-1300 | Room: Ballroom II & III
FP
Sat 17 1145

Freepaper Presentation: Intestinal microbiome in patients with retinal artery occlusion

1145-1150 | Room: Ballroom II & III
FP
Sat 17 1150

Freepaper Presentation: Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: 24-month results from the EVEREST II study

1150-1155 | Room: Ballroom II & III
FP
Sat 17 1155

Freepaper Presentation: Long-term outcomes 6-7 years after initiation of intensive anti-VEGF therapy in patients with exudative age-related macular degeneration

1155-1200 | Room: Ballroom II & III
FP
Sat 17 1200

Freepaper Presentation: Homocystein, vitamin D and lipidic metabolism in late AMD patients

1200-1205 | Room: Ballroom II & III
FP
Sat 17 1205

Freepaper Presentation: Prediction of diabetic retinopathy by quantifying retinal capillary density using optical coherence tomography angiography in diabetic patients

1205-1210 | Room: Ballroom II & III
FP
Sat 17 1210

Freepaper Presentation: Outcomes of retinal detachment surgeries in children with Stickler-syndrome

1210-1215 | Room: Ballroom II & III
FP
Sat 17 1215

Freepaper Presentation: Switching corticosteroids therapy for diabetic macular edema – 12 months follow-up

1215-1220 | Room: Ballroom II & III
FP
Sat 17 1220

Freepaper Presentation: Intrasession and between-visit variability of retinal microvascular parameters measured with the angiovue optical coherence tomograph in patients with diabetes

1220-1225 | Room: Ballroom II & III
FP
Sat 17 1225

Freepaper Presentation: Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes

1225-1230 | Room: Ballroom II & III
FP
Sat 17 1230

Freepaper Presentation:Peripapillary vascular changes in radiation optic neuropathy: An optical coherence tomography angiography grading

1230-1235 | Room: Ballroom II & III
FP
Sat 17 1235

Freepaper Presentation: Macular thickness changes after phacoemulsification with / without posterior central circular capsulorhexis

1235-1240 | Room: Ballroom II & III
FP
Sat 17 1240

Freepaper Presentation: Choroidal thickness changes after a single administration of energy drink in healthy subjects.

1240-1245 | Room: Ballroom II & III
FP
Sat 17 1245

Freepaper Presentation: Role of ILM peeling during vitreo-retinal surgery for rhegmatogenous retinal detachment in the development of post operative epiretinal membrane: a randomised trial

1245-1250 | Room: Ballroom II & III
FP
Sat 17 1250

Freepaper Presentation: Examination of early, near visual acuity after macular hole surgery by 27+G pars plana vitrectomy and gas insufflation

1250-1255 | Room: Ballroom II & III
FP
Sat 17 1255

Freepaper Presentation:Inverted ILM flap technique for the treatment of chronic and large Idiopathic MH with the use as a vital dye suspension `Vitreocontrast`

1255-1300 | Room: Ballroom II & III
FP
Sun 18 1300

Inverted ILM flap technique for the treatment of chronic and large Idiopathic MH with the use as a vital dye suspension `Vitreocontrast`

1300-1255 | Room: Ballroom II & III

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved